eriodictyol has been researched along with Lipid Metabolism Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, D; Huang, W; Liang, Y; Ma, L; Niu, H; Wen, L; Xia, Q | 1 |
1 other study(ies) available for eriodictyol and Lipid Metabolism Disorders
| Article | Year |
|---|---|
Eriodictyol 7‑O‑β‑D glucopyranoside from Coreopsis tinctoria Nutt. ameliorates lipid disorders via protecting mitochondrial function and suppressing lipogenesis.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Cell Line, Tumor; Coreopsis; Disease Models, Animal; Flavanones; Humans; Hypolipidemic Agents; Inhibitory Concentration 50; Lipid Metabolism Disorders; Lipid Peroxidation; Lipogenesis; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Plant Extracts; Reactive Oxygen Species | 2017 |